"VITALINK’S FULLY INTEGRATED NETWORK OF CLINICAL TRIALS SITES connects renowned physicians and medical professionals with site managers and coordinators to create a seamless trial experience that puts the patient first and produces trustworthy and consistent results"

During the past decade, VitaLink Research-Greenville conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VitaLink Research-Greenville" #1 sponsor was "ModernaTX, Inc." with 3 trials, followed by "Verona Pharma plc" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Abbott Molecular" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VitaLink Research-Greenville" #1 collaborator was "Iqvia Pty Ltd" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "VitaLink Research-Greenville" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Pulmonary Disease, Chronic Obstructive" (2 trials), "Alzheimer Disease" (1 trials), "Asthma" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "VitaLink Research-Greenville" in a lesser frequency.

Most popular intervention types in "VitaLink Research-Greenville" are "Drug" (12 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Active Comparator" (1 trials), "Alinity m HR HPV" (1 trials), "Aspirin (ASA) Oral Tablet - Pre-Treatment" (1 trials) and "Astegolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "VitaLink Research-Greenville" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "VitaLink Research-Greenville". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in VitaLink Research-Greenville, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in VitaLink Research-Greenville, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".